LSU Health Science Center

LSU Health Digital Scholar
Medical Research Day

2022 Medical Research Day Posters

Oct 13th, 12:00 AM

RADIANCE1: Reducing delAys in enDometrIAl caNcer CarE
Symptoms Through Gynecologic Oncology Referral
Rebecca Maitski
LSU Health Sciences Center- New Orleans

Jessica Anderson
LSU Health Sciences Center- New Orleans, jand22@lsuhsc.edu

Hannah Sibley
LSU Health Sciences Center- New Orleans, hsibl1@lsuhsc.edu

Nicole Catalano
LSU Health Sciences Center- New Orleans, ncatal@lsuhsc.edu

Kyla Maupin
LSU Health Sciences Center- New Orleans, kmaup2@lsuhsc.edu

See next page for additional authors

Follow this and additional works at: https://digitalscholar.lsuhsc.edu/sommrd
Part of the Oncology Commons

Recommended Citation
Maitski, Rebecca; Anderson, Jessica; Sibley, Hannah; Catalano, Nicole; Maupin, Kyla; Nair, Navya;
Castellano, Tara; Chapple, Andrew G.; and Jernigan, Amelia, "RADIANCE1: Reducing delAys in enDometrIAl
caNcer CarE Symptoms Through Gynecologic Oncology Referral" (2022). Medical Research Day. 54.
https://digitalscholar.lsuhsc.edu/sommrd/2022MRD/Posters/54

This Event is brought to you for free and open access by the School of Medicine at LSU Health Digital Scholar. It
has been accepted for inclusion in Medical Research Day by an authorized administrator of LSU Health Digital
Scholar. For more information, please contact aolini@lsuhsc.edu.

Presenter Information
Rebecca Maitski, Jessica Anderson, Hannah Sibley, Nicole Catalano, Kyla Maupin, Navya Nair, Tara
Castellano, Andrew G. Chapple, and Amelia Jernigan

This event is available at LSU Health Digital Scholar: https://digitalscholar.lsuhsc.edu/sommrd/2022MRD/Posters/54

RADIANCE1: Reducing delAys in enDometrIAl caNcer
CarE Symptoms Through Gynecologic Oncology Referral
Rebecca Maitski1; Jessica Anderson1; Hannah Sibley1; Nicole Catalano1; Kyla Maupin1; Navya Nair,
MD, MPH2; Tara Castellano, MD2; Andrew Chapple, PhD3; Amelia Jernigan, MD2
1LSU Health Sciences Center, School of Medicine, New Orleans, LA
Health Sciences Center, Department of Obstetrics and Gynecology, New Orleans, LA
3LSU Health Sciences Center, Biostatistics Program, School of Public Health, New Orleans, LA
2LSU

Introduction

Data

In this cohort of women seeking care at a university practice
in the Gulf South, we aimed to identify specific delays from
patient experience of abnormal uterine bleeding (AUB) to
referral to gynecologic oncology (GON) with a diagnosis of
endometrial cancer (EC).

Methods
A multicenter, IRB-approved retrospective chart review was
performed. Women diagnosed with Stage I-IV endometrial
cancer from 2013 to 2022 were included. Demographic and
clinical data were collected. Time frames between key events
were calculated. Timed events were censored if there was
insufficient data to make a calculation. Categorical
covariates were summarized with counts and percentages,
continuous variables were summarized via means and
standard deviations. Categorical covariates were compared
across groups using a fisher exact test, while continuous
variables were compared using t tests. Multivariable quasiPoisson regression was performed to predict each treatment
time difference for patients to determine if any disparities
existed. Time periods were evaluated for difference with
regards to race, insurance status, cancer stage, BMI, CCI and
distance from the clinic site.

Results
Of the 449 women included, 184 (43.7%) were Black-not
Hispanic. Most (76.2%) had stage I-II EC. The mean BMI
was 37.22 (SD= 10.35) and Charleston Comorbidity Index
(CCI) was 4.77 (SD= 2.41). Two-hundred twenty-four
patients had documented accounts of AUB prior to
diagnosis. Black patients were more likely than non-black
patients to report shorter stints of AUB before presenting
for evaluation: days (10.1% vs 9.6%), weeks (15% vs
11.3%), months (55.0% vs 41.7%), or years (19.3% vs
37.4%) (p value 0.025). There was no significant
difference with regards to days from gynecology (GYN)
referral to first GYN appointment, first GYN appointment
to first endometrial sampling, endometrial sampling to
pathology read diagnosing EC, or EC on pathology read to
review with patient. We noted a trend suggesting that
privately insured patients took 2.33 times as long to get
from first GYN appointment to sampling (95%CI= 0.975.43, p=0.053). Black patients waited 21.7 days for a
referral after pathology read confirming EC compared to
non-black patients who waited 9.1 days; this was 2.64
times as long as other patients to be referred
(95%CI=1.19-6.15, p=0.021). Otherwise, the time from
pathologic diagnosis of EC to GON referral was similar
between groups.

Conclusion
Bleeding Time to Gyn Onc Referral

We report time-to-outcomes for patient workup for EC
prior to seeing GON in a diverse patient population. Black
patients presented with more advanced disease and
comorbidities but reported shorter duration of AUB
leading up to their evaluation. This highlights the
importance of an expedient work up in this patient
population. Time from pathology read to GON referral
was 2.6 times longer for Black patients than non-Black
patients, representing an opportunity to address systematic
delays. These results highlight barriers to diagnosis and
work up of EC that are potentially actionable.

